Please provide your email address to receive an email when new articles are posted on . Bullous pemphigoid was the most prevalent autoimmune bullous disease in patients with coexistent psoriasis, ...
The top 5 most-read dermatology content of 2025 on AJMC.com included innovative advances from artificial intelligence ...
Please provide your email address to receive an email when new articles are posted on . Patients with bullous pemphigoid experienced increases in cardiovascular mortality risk at 1, 3 and 5 years ...
A Prescription Drug User Fee Act target date of June 20, 2025 has been set for the application. The Food and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics ...
November 16, 2010 — Cerebrovascular disease and dementia are significantly more prevalent among patients with bullous pemphigoid (BP) than in age-matched patients without the debilitating autoimmune ...
Proteomic profiling reveals molecular clusters and severity biomarkers in bullous pemphigoid, highlighting disease ...
Bullous pemphigoid is a potentially debilitating autoimmune bullous disease presenting with urticarial plaques, subepidermal bullae, erosions, and pruritus, classically in elderly individuals. This ...
We carried out a thorough and complete review of the husbandry and management practices in cooperation with the floor supervisor and animal caretakers and ruled out chemical, physical, solar and ...
Study met the primary and all key secondary endpoints in adults with moderate-to-severe disease; five times more patients achieved sustained disease remission with Dupixent than placebo Dupixent is ...
Five times more adults on Dupixent achieved sustained disease remission at 36 weeks compared to placebo; significant reductions were also seen in disease severity and itch Dupixent also significantly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback